Good company but still finding its way in merger - Recensione dipendente - Dipendente anonimo presso Merck

4,0
20 mar 2011
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good science - very thoughtful and innovative. C-levels seem to have good vision. Company has really transformed in the past few years.

Svantaggi

Still feeling the integration from the merger with Schering-Plough. Top level items done but now the middle layer which will take longer probably.

Esplora altre recensioni su Merck

5,0
15 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Manager is good. Communication is good.

Svantaggi

Salary is not very competitive

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto